These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 25996457

  • 1. Switching to low dose of plasma-derived factor VIII/vWF concentrates with Confact(®) -F as salvage immune tolerance induction in haemophilia A patients with inhibitors: five case reports from Japan.
    Nagao A, Oka T, Hanabusa H.
    Haemophilia; 2015 Sep; 21(5):e425-7. PubMed ID: 25996457
    [No Abstract] [Full Text] [Related]

  • 2. First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study.
    Kreuz W, Escuriola Ettingshausen C, Vdovin V, Zozulya N, Plyushch O, Svirin P, Andreeva T, Bubanská E, Campos M, Benedik-Dolničar M, Jiménez-Yuste V, Kitanovski L, Klukowska A, Momot A, Osmulskaya N, Prieto M, Šalek SZ, Velasco F, Pavlova A, Oldenburg J, Knaub S, Jansen M, Belyanskaya L, Walter O, ObsITI study group, ObsITI committee.
    Haemophilia; 2016 Jan; 22(1):87-95. PubMed ID: 26202305
    [Abstract] [Full Text] [Related]

  • 3. Immune tolerance induction with highly purified plasma-derived factor VIII containing von Willebrand factor in hemophilia A patients with high-responding inhibitors.
    Orsini F, Rotschild C, Beurrier P, Faradji A, Goudemand J, Polack B.
    Haematologica; 2005 Sep; 90(9):1288-90. PubMed ID: 16154861
    [Abstract] [Full Text] [Related]

  • 4. Immune tolerance induction with a factor VIII concentrate containing von Willebrand factor (Haemoctin SDH®) in 14 patients with severe haemophilia A.
    Bidlingmaier C, Kurnik K, Escuriola-Ettingshausen C, Jager R, Klamroth R, Male C, Marosi A, Nemes L, von Stackelberg A, Kreuz W.
    Haemophilia; 2011 Sep; 17(5):e837-40. PubMed ID: 21649797
    [No Abstract] [Full Text] [Related]

  • 5. Use of Haemate(®) P as immune tolerance induction in patients with severe haemophilia A who failed previous induction attempts: a multicentre observational study.
    Rothschild C, D'Oiron R, Borel-Derlon A, Gruel Y, Navarro R, Negrier C.
    Haemophilia; 2013 Mar; 19(2):281-6. PubMed ID: 23038998
    [Abstract] [Full Text] [Related]

  • 6. von Willebrand factor in factor VIII concentrates protects against neutralization by factor VIII antibodies of haemophilia A patients.
    Kallas A, Talpsep T.
    Haemophilia; 2001 Jul; 7(4):375-80. PubMed ID: 11442642
    [Abstract] [Full Text] [Related]

  • 7. Von Willebrand factor-containing factor VIII concentrates and inhibitors in haemophilia A. A critical literature review.
    Franchini M, Lippi G.
    Thromb Haemost; 2010 Nov; 104(5):931-40. PubMed ID: 20838738
    [Abstract] [Full Text] [Related]

  • 8. Immune tolerance induction using a factor VIII/von Willebrand factor concentrate (BIOSTATE), with or without immunosuppression, in Australian paediatric severe haemophilia A patients with high titre inhibitors: a multicentre, retrospective study.
    Robertson JD, Higgins P, Price J, Dunkley S, Barrese G, Curtin J.
    Thromb Res; 2014 Nov; 134(5):1046-51. PubMed ID: 25267706
    [Abstract] [Full Text] [Related]

  • 9. More than a decade of international experience with a pdFVIII/VWF concentrate in immune tolerance.
    Santagostino E.
    Haemophilia; 2013 Jan; 19 Suppl 1():8-11. PubMed ID: 23278994
    [Abstract] [Full Text] [Related]

  • 10. Immune tolerance induction with high von Willebrand factor/factor VIII content ratio concentrate in children with haemophilia A and high-responding inhibitor.
    Platokouki H, Pergantou H, Xafaki P, Komitopoulou A, Aronis S.
    Haemophilia; 2009 Mar; 15(2):617-9. PubMed ID: 19175417
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Primary and rescue immune tolerance induction in children and adults: a multicentre international study with a VWF-containing plasma-derived FVIII concentrate.
    Oldenburg J, Jiménez-Yuste V, Peiró-Jordán R, Aledort LM, Santagostino E.
    Haemophilia; 2014 Jan; 20(1):83-91. PubMed ID: 24354480
    [Abstract] [Full Text] [Related]

  • 13. Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response.
    Gringeri A, Musso R, Mazzucconi MG, Piseddu G, Schiavoni M, Pignoloni P, Mannucci PM, RITS-FITNHES Study Group.
    Haemophilia; 2007 Jul; 13(4):373-9. PubMed ID: 17610550
    [Abstract] [Full Text] [Related]

  • 14. Successful immune tolerance induction with factor VIII/von Willebrand factor concentrate in an elderly patient with severe haemophilia A and a high responder inhibitor.
    Rivolta GF, Di Perna C, Franchini M, Riccardi F, Ippolito L, Lombardi M, Tagliaferri A.
    Blood Transfus; 2010 Jan; 8(1):66-8. PubMed ID: 20104281
    [No Abstract] [Full Text] [Related]

  • 15. Inhibitors in haemophilia A: the role of VWF/FVIII concentrates--a meeting report.
    Kaveri S, Gringeri A, Heisel-Kurth M, Kreuz W.
    Haemophilia; 2009 Mar; 15(2):587-91. PubMed ID: 19347997
    [No Abstract] [Full Text] [Related]

  • 16. Novel therapies for immune tolerance in haemophilia A.
    Collins PW.
    Haemophilia; 2006 Dec; 12 Suppl 6():94-100; discussion 100-1. PubMed ID: 17123401
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Novel investigations on the protective role of the FVIII/VWF complex in inhibitor development.
    Mannucci PM, Shi Q, Bonanad S, Klamroth R.
    Haemophilia; 2014 Sep; 20 Suppl 6():2-16. PubMed ID: 24975700
    [Abstract] [Full Text] [Related]

  • 19. The role of VWF for the success of immune tolerance induction.
    Kreuz W.
    Thromb Res; 2008 Sep; 122 Suppl 2():S7-S12. PubMed ID: 18549910
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.